· By Sanofi Admin

Drug Development 101: Preclinical Research

Author: Doug Keller, Global Head of Preclinical Safety Development Projects
How much do you know about the types of studies that researchers need to conduct before a new therapy can be approved for use in humans?
Many are familiar with clinical trials, since they involve human volunteers. But before clinical trials can take place, each experimental treatment […]

VIEW FULL POST
 · By Sanofi Admin

Big Data, Better Knowledge: Understanding Diabetes Through Unique Collaborations

SANOFI_2011_Quadri

This post was authored by Sridar Natesan, PhD, Vice President, Strategic Initiatives & Scientific Relations at Sanofi
Alarmingly, over 29 million Americans have diabetes and the disease ranks as the 7th leading cause of death in the U.S.  Diabetes costs in the US have soared to over $245 billion, accounting for direct medical costs and the […]

VIEW FULL POST
 · By Sanofi Admin

Strategic Advisory Group of Experts on Immunization Convened by the WHO Recommends Use of Sanofi Pasteur’s Dengue Vaccine in Endemic Countries

SANOFI_2011_Quadri

Sanofi and our vaccines global vaccines business unit, Sanofi Pasteur, announced that the Strategic Advisory Group of Experts on Immunization (SAGE) has issued recommendations to the WHO on the use of its dengue vaccine.
WHO group backs Sanofi's vaccine in areas with high dengue rates https://t.co/KPavc03cZV
— Reuters Health (@Reuters_Health) April 15, 2016

The recommendations from the SAGE are based […]

VIEW FULL POST